Giuseppe Scalabrino

Milan, 20133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Journal: Biomedicines

Published: February 16, 2022

New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?

New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?

Journal: Frontiers in neurology

Published: August 06, 2021

Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview.

Epidermal Growth Factor in the CNS: A Beguiling Journey from Integrated Cell Biology to Multiple Sclerosis. An Extensive Translational Overview.

Journal: Cellular and molecular neurobiology

Published: July 31, 2020

Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.

Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.

Journal: Clinical breast cancer

Published: January 28, 2020

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF.

Journal: Journal of neuroimmunology

Published: March 20, 2019

Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.

Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.

Journal: Journal of the neurological sciences

Published: May 27, 2015

Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord.

Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord.

Journal: Neuroscience

Published: November 05, 2014

Relationships between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system.

Relationships between cobalamin, epidermal growth factor, and normal prions in the myelin maintenance of central nervous system.

Journal: The international journal of biochemistry & cell biology

Published: July 17, 2014

Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Journal: Journal of neurology

Published: August 02, 2013

Cobalamin and normal prions: a new horizon for cobalamin neurotrophism.

Cobalamin and normal prions: a new horizon for cobalamin neurotrophism.

Journal: Biochimie

Published: October 12, 2012

Normal prions as a new target of cobalamin (vitamin B12) in rat central nervous system.

Normal prions as a new target of cobalamin (vitamin B12) in rat central nervous system.

Journal: Clinical chemistry and laboratory medicine

Published: July 23, 2012

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: June 27, 2012

Showing 1-12 of 24

Last Updated: 09/26/2026